Novartis Ag (NVS) Selling, General & Administrative (2009 - 2025)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
2.93 Bn |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
6.03 Bn |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
3.58 Bn |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
2.70 Bn |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
1.60 Bn |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1.45 Bn |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
2.96 Bn |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
1.62 Bn |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
-3.44 Bn |
| Dec 31, 2024 |
-5.93 Bn |
| Jun 30, 2024 |
-3.09 Bn |
| Dec 31, 2023 |
-5.98 Bn |
| Jun 30, 2023 |
-7.13 Bn |
| Mar 31, 2023 |
-542.00 Mn |
| Dec 31, 2022 |
-565.00 Mn |
| Sep 30, 2022 |
-478.00 Mn |
| Jun 30, 2022 |
-7.09 Bn |
| Mar 31, 2022 |
-513.00 Mn |
| Dec 31, 2021 |
-568.00 Mn |
| Sep 30, 2021 |
-480.00 Mn |
| Jun 30, 2021 |
-3.75 Bn |
| Mar 31, 2021 |
-502.00 Mn |
| Dec 31, 2020 |
-572.00 Mn |
| Sep 30, 2020 |
-488.00 Mn |
| Jun 30, 2020 |
-6.85 Bn |
| Mar 31, 2020 |
-520.00 Mn |
| Mar 31, 2019 |
-562.00 Mn |
| Dec 31, 2018 |
-727.00 Mn |
| Sep 30, 2018 |
-690.00 Mn |
| Jun 30, 2018 |
-4.19 Bn |
| Mar 31, 2018 |
-602.00 Mn |
| Dec 31, 2017 |
-637.00 Mn |
| Sep 30, 2017 |
-641.00 Mn |
| Jun 30, 2017 |
-3.81 Bn |
| Mar 31, 2017 |
-605.00 Mn |
| Dec 31, 2016 |
-592.00 Mn |
| Sep 30, 2016 |
-456.00 Mn |
| Jun 30, 2016 |
-582.00 Mn |
| Mar 31, 2016 |
-564.00 Mn |
| Dec 31, 2015 |
-710.00 Mn |
| Sep 30, 2015 |
-573.00 Mn |
| Jun 30, 2015 |
-601.00 |
| Mar 31, 2015 |
-591.00 |
| Dec 31, 2014 |
-736.00 |
| Sep 30, 2014 |
-593.00 |
| Jun 30, 2014 |
-638.00 |
| Mar 31, 2014 |
-649.00 |
| Dec 31, 2013 |
-695.00 |
| Sep 30, 2013 |
-641.00 |
| Jun 30, 2013 |
-619.00 |
| Mar 31, 2013 |
-761.00 |
| Sep 30, 2012 |
-693.00 |
| Jun 30, 2012 |
-737.00 |
| Mar 31, 2012 |
-719.00 |
| Dec 31, 2011 |
-804.00 |
| Sep 30, 2011 |
-734.00 |
| Jun 30, 2011 |
-738.00 |
| Mar 31, 2011 |
-694.00 |
| Dec 31, 2010 |
-794.00 |
| Sep 30, 2010 |
-574.00 |
| Jun 30, 2010 |
-543.00 |
| Mar 31, 2010 |
-570.00 |
| Dec 31, 2009 |
-692.00 |
| Sep 30, 2009 |
-542.00 |
| Jun 30, 2009 |
-542.00 |
| Mar 31, 2009 |
-505.00 |
